Table 4.

Overview of meta-analytic results of the finer-grained phase comparisons.

To From	Mid-To-Late Follicular	Ovulatory	Early-To-Mid Luteal	Premenstrual
Menstrual	d = 0.23 95% CI (−0.08, 0.55) nstudies = 10; nindividuals = 349	d = 0.35 95% CI (−0.45, 1.16) nstudies = 4; nindividuals = 47	d = 0.28 95% CI (−0.52, 1.08) nstudie; = 4; nindividuals = 86	d = −1.17 95% CI (−2.18, −0.17) nstudies = 5; nindividuals = 200
Mid-to-late follicular		nstudies = 1; nindividuals = 13	d = −0.14 95% CI (−0.60, 0.32) nstudies = 3; nindividuals = 53	d = −1.32 95% CI (−2.35, −0.29) nstudies = 8; nindividuals = 280
Ovulatory			d = −0.06 95% CI (−0.64, 0.51) nstudies = 2; nindividuals = 23	nstudies = 1; nindividuals = 13
Early-to-mid luteal				d = 0.20 95% CI (−0.25, 0.64) nstudies = 2; nindividuals = 39

Note. Significant effects (due to 95% CI not intersecting 0) are bolded. Negative effect sizes indicate a decrease in CVA.